Sign in

CIK 0001398733 · Non-accelerated filer<br>Smaller reporting company

Aquestive Therapeutics, Inc.

Sign in to watch
Ticker
AQST
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
208623253
Phone
908-941-1900
Business address
184 LIBERTY CORNER ROAD, SUITE 305, WARREN, NJ
Former names
MonoSol Rx, Inc.
Open-market buys, last 90 days
$99,331
in 1 filing
Open-market sales, last 90 days
$378,930
in 4 filings, $379K under 10b5-1 plans

Net −$279,599. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Barber Daniel −$333K President and CEO sold 11% of stake
  2. Daly Richard J +$99K Director 1 filing
  3. Korczynski Sherry −$46K Chief Commercial Officer sold 4% of stake
Date Insider Transaction Shares Price Value Owned after
2019-08-12 Boyd Peter E. SVP-Bus. Process & Info. Tech. Purchase +600 $3.81 $2K 50,239
2019-08-09 Kendall Keith J CEO and President Purchase +2,000 $3.84 $8K 648,581
2019-08-09 Kendall Keith J CEO and President Purchase +1,000 $3.93 $4K 649,581
2019-08-09 Kendall Keith J CEO and President Purchase +2,000 $4.00 $8K 651,581
2019-08-09 Wood Theresa SVP-HR and Org. Development Purchase +1,000 $3.99 $4K 80,765
2019-08-09 BRAENDER LORI J SVP, General Counsel Purchase +10,000 $4.07 $41K 11,000
2019-06-30 Kendall Keith J CEO and President Option exercise +329 646,735
2019-06-30 Kendall Keith J CEO and President Shares withheld for taxes −154 $4.20 $647 646,581
2019-06-30 Kendall Keith J CEO and President Option exercise · Restricted Stock Units −329 1,320
2019-06-30 Schobel Alexander Mark Chief Innovation/Tech Officer Option exercise +329 1,036,018
2019-06-30 Schobel Alexander Mark Chief Innovation/Tech Officer Shares withheld for taxes −149 $4.20 $626 1,035,869
2019-06-30 Schobel Alexander Mark Chief Innovation/Tech Officer Option exercise · Restricted Stock Units −329 1,320
2019-06-13 BROWN GREGORY B Director Grant or award · Stock Option (Right to Purchase) +13,350 13,350
2019-06-13 Lurker Nancy Director Grant or award · Stock Option (Right to Purchase) +13,350 13,350
2019-06-13 Cochran John Director Grant or award · Stock Option (Right to Purchase) +13,350 13,350
2019-06-13 COSTA SANTO J Director Grant or award · Stock Option (Right to Purchase) +13,350 13,350
2019-06-13 Scibetta James S Director Grant or award · Stock Option (Right to Purchase) +13,350 13,350
2019-06-13 BRATTON DOUGLAS K Director Grant or award · Stock Option (Right to Purchase) +13,350 13,350
2019-05-31 Schobel Alexander Mark Chief Innovation/Tech Officer Option exercise +14,572 1,042,280
2019-05-31 Schobel Alexander Mark Chief Innovation/Tech Officer Shares withheld for taxes −6,591 $3.72 $25K 1,035,689

Page 19 of 24 · 462 trades